Survey of the distribution of lesion size in multiple sclerosis: Implication for the measurement of total lesion load

Journal of Neurology Neurosurgery and Psychiatry

Volumn 63, Issue 4, 1997, Pages 452-455

  Wang, Liqun ^a   Lai, H M ^a   Thompson, A J ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Lesion volume; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; WHITE MATTER;

EID: 0030818570     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.63.4.452     Document Type: Article

References (15)

1. Paty DW, Li DKB, the INFB MS Study Group. Interferon β-1b is effective in relapsing remitting multiple sclerosis. ii. MRI analysis results of a multicenter, randomized, double-blind, placebo controlled trial. Neurology 1993;43:662-7.
2. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16.
3. Clarke LP, Velthuizen RP, Camacho MA, et al. MRI segmentation: methods and applications. Magn Reson Imaging 1995;13:343-68.
4. Grimaud JP, Lai M, Plummer D, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996; 14:495-505.
5. Goodkin DE, Ross JS, et al. Magnetic resonance imaging lesion enlargement in multiple sclerosis. Arch Neurol 1992; 49:261-3.
6. Fillipi M, Horsfield MA, Tofts PS, et al. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 1995;118:1601-12.
7. Wang, L, Thorpe JW, Tofts PS. Evaluation of cluster analysis in multiple sclerosis lesion segmentation. Proceedings of the Annual Conference of Society of Magnetic Resonance in Medicine 1995;2:709.
8. Evans A, Frank JA, Antel J, Miller DH. The role of MRI in clinical trials of multiple sclerosis: comparison of image processing techniques. Ann Neurol 1997;41:125-32.
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
10. van Oosten BW, Lai M, Barkhof F, et al. A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis. Multiple Sclerosis 1996;1:339-42.
11. Wicks DAG, Barker GJ, Tofts PS. Correction of intensity non-uniformity in MR images of any orientation. Magn Reson Imaging 1992;11:183-96.
12. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 1990;30:631-4.
13. Thompson AJ, Kermode AG, Wicks DAG, et al. Major differences in the dynamics of primary and secondary progressive MS. Ann Neurol 1991;29:53-62.
14. Filippi M, Horsfield MA, Campi A, et al. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38:749-54.
15. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.